Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Optical UVA biosensor platform for high-throughput testing of UV blockers.

The Journal of investigative dermatology·2026

Same author

Self-driving medicine: closed-loop therapeutics for autonomous disease control.

Trends in biotechnology·2026

Same author

Bioengineering CAR-T cells to function in hostile tumor microenvironments.

Trends in biotechnology·2026

Same author

A synthetic angiotensin II/ACE2-based hormone shunt controlling experimental hypertension.

Nature communications·2026

Same author

Next-generation programmable cell therapies for precision medicine.

Nature reviews. Genetics·2026

Same author

Traceless Regulation of Genetic Circuitry.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Same journal

Topological skeleton analysis for network-based shape representation in biology and beyond.

iScience·2026

Same journal

Condition-specific neural signatures of reactivation during post-retrieval rest: An EEG study.

iScience·2026

Same journal

Multi-chaotic signal identification employing a causal cross-correlation neural network.

iScience·2026

Same journal

Repeated insertions at positions 261-280 in KPC-2 highlight a ceftazidime-avibactam resistance hotspot.

iScience·2026

Same journal

ROS inhibits microtubule dynamics and cell growth heterogeneity during Arabidopsis sepal morphogenesis.

iScience·2026

Same journal

Type 1 diabetes alters early macrophage-<i>Mycobacterium tuberculosis</i> transcriptional coordination during infection.

iScience·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 1, 2025

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Engineering autonomous closed-loop designer cells for disease therapy.

Mohamed Mahameed¹, Martin Fussenegger^1,2

¹ETH Zurich, Department of Biosystems Science and Engineering, Mattenstrasse 26, CH-4058 Basel, Switzerland.

|March 4, 2022

Summary

This summary is machine-generated.

Engineered designer cells offer autonomous therapeutic delivery for chronic diseases, detecting disease markers to release treatments without external inducers. This approach improves patient compliance and quality of life.

Keywords:

Biopharmaceuticals Molecular genetics Synthetic biology

More Related Videos

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Published on: December 12, 2019

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression

Published on: October 6, 2019

Related Experiment Videos

Last Updated: Oct 1, 2025

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Published on: December 12, 2019

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression

A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression

Published on: October 6, 2019

Area of Science:

Synthetic biology
Cellular engineering
Biotechnology

Background:

Mammalian cell engineering enables therapeutic agent delivery for chronic diseases.
Current methods rely on exogenous inducers, causing patient compliance and side effect issues.
Autonomous, closed-loop therapeutic cells (designer cells) are being developed to overcome these limitations.

Purpose of the Study:

To review recent advancements in designer cell engineering.
To explore the in vivo therapeutic applications of designer cells.
To focus on the molecular mechanisms and signaling pathways utilized in designer cells.

Main Methods:

Engineering mammalian cells with synthetic biology tools.
Developing sensing modules to detect disease markers.
Implementing signaling cascades for controlled therapeutic agent secretion.

Main Results:

Designer cells can autonomously detect disease markers.
These cells can release therapeutic agents in a timely and quantitative manner.
No exogenous inducers are required for therapeutic delivery.

Conclusions:

Designer cells represent a promising advancement in therapeutic delivery systems.
Autonomous, closed-loop systems enhance patient compliance and quality of life.
Further research into molecular mechanisms and signaling pathways will optimize designer cell therapies.